Vanguard Group’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-294,104
| Closed | -$2.7M | – | 4311 |
|
|
2025
Q1 | $2.7M | Buy |
294,104
+37,149
| +14% | +$233K | ﹤0.01% | 3385 |
|
|
2024
Q4 | $1.72M | Sell |
256,955
-1
| -0% | -$9 | ﹤0.01% | 3616 |
|
|
2024
Q3 | $2.58M | Hold |
256,956
| – | – | ﹤0.01% | 3480 |
|
|
2024
Q2 | $4.01M | Sell |
256,956
-25,885
| -9% | -$434K | ﹤0.01% | 3350 |
|
|
2024
Q1 | $6.19M | Buy |
282,841
+4,194
| +2% | +$93.1K | ﹤0.01% | 3209 |
|
|
2023
Q4 | $5.39M | Buy |
278,647
+23,882
| +9% | +$436K | ﹤0.01% | 3260 |
|
|
2023
Q3 | $4.7M | Buy |
254,765
+15,170
| +6% | +$273K | ﹤0.01% | 3276 |
|
|
2023
Q2 | $4.42M | Buy |
239,595
+29,903
| +14% | +$707K | ﹤0.01% | 3366 |
|
|
2023
Q1 | $6.07M | Sell |
209,692
-56
| -0% | -$1.49K | ﹤0.01% | 3213 |
|
|
2022
Q4 | $5.82M | Buy |
209,748
+70,546
| +51% | +$2.68M | ﹤0.01% | 3235 |
|
|
2022
Q3 | $7.64M | Buy |
139,202
+5,563
| +4% | +$305K | ﹤0.01% | 3090 |
|
|
2022
Q2 | $7.34M | Buy |
133,639
+7,354
| +6% | +$271K | ﹤0.01% | 3163 |
|
|
2022
Q1 | $4.68M | Sell |
126,285
-32,884
| -21% | -$1.17M | ﹤0.01% | 3565 |
|
|
2021
Q4 | $3.87M | Buy |
159,169
+56,089
| +54% | +$1.88M | ﹤0.01% | 3750 |
|
|
2021
Q3 | $4.64M | Buy |
103,080
+472
| +0.5% | +$19.8K | ﹤0.01% | 3710 |
|
|
2021
Q2 | $4.79M | Sell |
102,608
-11,970
| -10% | -$611K | ﹤0.01% | 3632 |
|
|
2021
Q1 | $6.34M | Buy |
114,578
+6,315
| +6% | +$384K | ﹤0.01% | 3401 |
|
|
2020
Q4 | $6.72M | Buy |
108,263
+5,828
| +6% | +$357K | ﹤0.01% | 3200 |
|
|
2020
Q3 | $5.99M | Buy |
102,435
+14,255
| +16% | +$1.06M | ﹤0.01% | 3058 |
|
|
2020
Q2 | $9.84M | Buy |
88,180
+1,470
| +2% | +$105K | ﹤0.01% | 2780 |
|
|
2020
Q1 | $5.84M | Buy |
86,710
+1,480
| +2% | +$149K | ﹤0.01% | 2906 |
|
|
2019
Q4 | $11.8M | Buy |
85,230
+16,809
| +25% | +$2.18M | ﹤0.01% | 2779 |
|
|
2019
Q3 | $7.18M | Buy |
68,421
+19,214
| +39% | +$1.92M | ﹤0.01% | 2990 |
|
|
2019
Q2 | $5.23M | Sell |
49,207
-14,019
| -22% | -$1.85M | ﹤0.01% | 3156 |
|
|
2019
Q1 | $9.77M | Buy |
63,226
+6,359
| +11% | +$737K | ﹤0.01% | 2836 |
|
|
2018
Q4 | $5.29M | Buy |
56,867
+4,888
| +9% | +$698K | ﹤0.01% | 3069 |
|
|
2018
Q3 | $9.69M | Buy |
51,979
+827
| +2% | +$236K | ﹤0.01% | 2936 |
|
|
2018
Q2 | $21.5M | Buy |
51,152
+31,499
| +160% | +$10.6M | ﹤0.01% | 2534 |
|
|
2018
Q1 | $5.9M | Buy |
19,653
+2,237
| +13% | +$620K | ﹤0.01% | 3075 |
|
|
2017
Q4 | $4.94M | Buy |
+17,416
| New | +$4.9M | ﹤0.01% | 3139 |
|
Vanguard Group's OPTN Position: Q2 2025 in Review
Vanguard Group sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 294,104 shares — an estimated $2.7M sold.
Vanguard Group first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $21.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Vanguard Group reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Vanguard Group sold 294,104 OptiNose shares in Q2 2025, an estimated $2.7M.
- Vanguard Group first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- Vanguard Group's OptiNose position peaked at $21.5M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.